查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1748710

电子药物市场，按产品、按类型、按应用、按国家和地区 - 行业分析、市场规模、市场份额及预测（2024 年至 2032 年）

Electroceuticals Market, By Product, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 375 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年电子药物市场规模价值为 224.5645 亿美元，从 2024 年到 2032 年的复合年增长率为 7.60%。

电子药物市场-市场动态

神经系统疾病盛行率上升推动需求

神经系统疾病发生率的不断上升，大大促进了电疗市场的成长。由于人口老化、生活方式的改变以及诊断能力的提高等因素，帕金森氏症、癫痫、慢性忧郁症、阿兹海默症和多发性硬化症等疾病的盛行率日益上升。这些疾病的治疗选择通常有限，而传统的药物疗法可能无法达到理想的疗效或产生不良副作用。因此，人们越来越倾向于寻求更精准、更少系统性影响的先进治疗方案。电疗透过电刺激直接作用于引起疾病症状的神经迴路，提供了一种新颖的治疗方法。深部脑部刺激 (DBS)、迷走神经刺激 (VNS) 和脊髓刺激 (SCS) 等技术在治疗复杂的神经系统疾病方面已取得显着成效。由于这些设备在症状控制和患者生活品质方面取得了更好的效果，它们逐渐受到医疗服务提供者和患者的青睐。

电子药物市场-关键见解

根据我们的研究分析师，全球电子药物市场预计在 2024 年至 2032 年期间的复合年增长率约为 7.60%。

2023 年按产品细分，心臟节律器和植入式心律转復除颤器类别占据了市场主导地位。

根据类型，植入式电疗设备在 2023 年产生的收入最多。

按地区划分，2023年北美是收入最高的地区。

电子药物市场-細項分析：

全球电子药物市场分为三类：产品、类型、应用和地区。

电疗市场按产品细分为心臟节律器和植入式心律转復除颤器 (ICD)、人工耳蜗、神经调节器和视网膜植入物。其中，心臟起搏器和ICD预计将占据市场主导地位。这种主导地位主要源自于全球心血管疾病（包括心律不整和心臟衰竭）的高发生率，这些疾病需要透过心臟电刺激及时介入。这些设备因其疗效可靠、技术进步以及在更容易患心臟病的老龄化人群中的日益普及而被广泛采用。此外，已开发国家的报销政策以及微创心臟设备的持续创新进一步推动了它们的普及。虽然人工耳蜗和神经调节器是成长型细分市场，但心臟设备长期的临床应用、强大的基础设施以及挽救生命的潜力，确保了它们在市场上的领先地位。由于心血管疾病仍然是全球死亡的主要原因，预计对这些设备的需求将保持强劲。

按类型划分，电疗市场分为植入式电疗设备和非侵入式电疗设备。其中，植入式电疗设备占市场主导地位。这种主导地位归因于其在治疗心律不整、癫痫和帕金森氏症等危重慢性疾病的广泛应用。心臟节律器、植入式心律转復除颤器 (ICD)、深部脑部刺激器和迷走神经刺激器等装置提供高效、长期获益的标靶治疗，使其成为治疗重症的首选。植入式设备也受益于小型化、电池技术和设备编程的不断进步，从而提高了其安全性和性能。此外，它们在已开发市场的长期临床认可和健全的报销框架支持其更广泛的应用。儘管非侵入性设备在轻度疾病和家庭治疗中越来越受欢迎，但植入式电疗因其治疗精度和救生应用而继续引领市场。

电子药物市场—地理洞察

从地理分布来看，电子药物市场遍布北美、亚太、拉丁美洲、欧洲、中东和非洲。这些地区根据业务开展的国家进一步划分。

北美占全球电子药物市场最大份额，其中美国是主要贡献者。该地区受益于强大的医疗基础设施、高昂的医疗支出以及先进医疗技术的快速普及。帕金森氏症、癫痫、心血管疾病和听力损失等慢性疾病的盛行率不断上升，推动了对心臟起搏器、植入式除颤器 (ICD)、人工耳蜗和深部脑刺激器等植入式装置的持续需求。此外，美敦力、雅培和波士顿科学等主要市场参与者的存在，确保了强大的研发和商业化管道。美国食品药物管理局 (FDA) 等监管机构为医疗器材审批提供了明确的框架，促进了创新和市场准入。此外，优惠的报销政策以及日益增强的医患意识进一步支持了市场扩张。美国在神经调节和生物电子医学的临床试验和学术研究方面也处于领先地位。加拿大虽然市场规模较小，但也透过公共医疗计划和增加先进治疗的可近性做出了贡献。随着该地区继续投资个人化医疗、数位健康整合和微型生物电子设备，北美预计将在未来几年保持其在电子药物领域的领先地位。

欧洲是全球第二大电子药物市场，其驱动力来自人口老化以及神经系统和心血管疾病发生率的上升。德国、英国和法国等国家凭藉其先进的医疗基础设施、全面的保险覆盖和积极的监管支持，成为主要的收入来源。该地区对采用创新治疗技术表现出强烈的意愿，包括深部脑部刺激、迷走神经刺激和人工耳蜗。欧洲拥有许多致力于生物电子医学发展的知名学术机构和研究中心。来自公共卫生机构和欧盟的资金支持促进了临床研究和设备创新的发展。此外，患者对神经调节疗法的高度认知和临床医生的专业知识也提高了该疗法的采用率。许多欧洲国家的报销框架支持高成本医疗技术的普及，从而提高了患者对电子药物治疗的接受度。

电子药物市场-竞争格局：

电疗市场竞争激烈，美敦力、波士顿科学公司和雅培等老牌医疗器材製造商占据主导地位，它们凭藉雄厚的研发实力、法规专业知识和全球分销网络，积极拓展产品组合。这些公司专注于透过心臟器材、神经调节和听力植入物领域的创新解决方案来拓展产品组合。 LivaNova Plc、Cochlear Ltd. 和 Sonova 专注于迷走神经刺激和人工耳蜗等细分市场，致力于提升神经系统和听觉障碍患者的治疗效果。同时，Axonics Inc.、Neuronetics、ElectroCore Inc. 和 NeuroPace Inc. 等新兴企业正透过微创和穿戴式神经调节技术推动创新，这些技术旨在治疗忧郁症、癫痫和膀胱过动症等疾病。微创医疗科学公司和 Nervo Corp. 分别正在亚洲和北美拓展业务。这种竞争格局以策略性收购、合作伙伴关係和持续的产品开发为特征，创造了一个充满活力的环境，促进了技术进步和电疗疗法在全球范围内的广泛应用。

最新动态：

2024 年 4 月，Axonics Inc. 宣布 FDA 批准其下一代可充电骶神经调节系统，该系统可提供更长的电池寿命并提高患者的舒适度。

2024 年 1 月，波士顿科学公司收购了专门从事骨内椎基底神经消融治疗的公司 Relievant Medsystems，以扩大其慢性疼痛管理产品组合。

2023 年 11 月，雅培的 Eterna(TM) 脊髓刺激系统获得 CE 标誌认证，该系统采用其最小的可植入可充电神经刺激器，专为缓解慢性疼痛而设计。

2023 年 9 月，Neuronetics 在欧洲新市场推出了 NeuroStar 先进治疗系统，扩大了重度忧郁症患者使用经颅磁刺激 (TMS) 的管道。

目录

第一章：电子药物市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 电子药物市场依产品分类
    • 电子药物市场片段（按类型）
    • 电子药物市场片段（按应用）
    • 各国电子药物市场概况
    • 电疗市场按地区细分
  • 竞争洞察

第三章：电子药物主要市场趋势

  • 电子药物市场驱动因素
    • 市场驱动因素的影响分析
  • 电子药物市场限制
    • 市场限制的影响分析
  • 电子药物市场机会
  • 电子药物市场未来趋势

第四章：电子药物产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：电子药物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长细分市场
    • 最鬆散的细分市场
    • 边际损失部分

第六章：电子药物市场格局

  • 2023年电子药物市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：电子药物市场－依产品分类

  • 概述
    • 按产品细分的市占率分析
    • 心臟节律器和植入式心律转復除颤器
    • 人工耳蜗
    • 神经调节剂
      • 脊髓刺激器
      • 深部脑部刺激器
      • 迷走神经刺激器
      • 荐神经刺激器
      • 胃电刺激器
      • 经颅磁刺激器
      • 呼吸电刺激器
      • 三叉神经刺激器
      • 反应性神经刺激器
    • 视网膜植入物

第 8 章：电子药物市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 植入式电疗设备
    • 非侵入性电疗设备

第九章：电子药物市场－按应用

  • 概述
    • 按应用细分市场占有率分析
    • 心臟节律器和植入式心律转復除颤器
      • 心律不整
      • 心臟衰竭
      • 其他心臟节律器和ICD应用
    • 脊髓刺激器
      • 慢性疼痛
      • 背部手术失败综合症
      • 缺血
    • 深部脑部刺激器
      • 帕金森氏症
      • 震颤
      • 沮丧
      • 其他资料库应用程式
    • 荐神经刺激器
      • 尿失禁
      • 大便失禁
    • 迷走神经刺激器，
      • 癫痫
      • 其他 Vns 应用
    • 胃电刺激器
      • 胃轻瘫
      • 肥胖
    • 经皮神经电刺激器
      • 难治性忧郁症
      • 其他应用
    • 经颅磁刺激器
      • 沮丧
      • 偏头痛
    • 呼吸电刺激器
      • 脊髓损伤
    • 三叉神经刺激器
      • 注意力不足过动症
      • 偏头痛

第 10 章：电子药物市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美电子药物主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲电子药物主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测，按应用
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区电子药物主要製造商
    • 亚太市场规模及预测（按国家/地区）
    • 亚太市场规模及预测（按产品）
    • 亚太市场规模及预测（按类型）
    • 亚太市场规模及预测（按应用）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲电子药物主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲的电子药物主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模和预测（按类型）
    • 中东和非洲市场规模和预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：电子药物产业主要供应商分析

  • 竞争仪錶板
  • 公司简介
    • Medtronic
    • Boston Scientific Corporation
    • Abbott
    • Livanova Plc
    • Cochlear Ltd.
    • Microport Scientific Corporation
    • Sonova
    • Nervo Corp.
    • Axonics Inc.
    • Neuronetics
    • Electrocore Inc.
    • Neuropace Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5243

REPORT HIGHLIGHT

Electroceuticals Market size was valued at USD 22,456.45 Million in 2024, expanding at a CAGR of 7.60% from 2024 to 2032.

Electroceuticals, also known as bioelectronic medicines, are a class of therapeutic devices that use electrical impulses to modulate the body's neural circuits, offering an alternative or complement to pharmaceutical treatments. These devices target specific nerves or brain regions to treat various medical conditions, including chronic pain, epilepsy, Parkinson's disease, depression, and even inflammatory disorders. Unlike traditional pharmaceuticals that rely on chemical interactions within the body, electroceuticals operate by influencing the electrical signaling pathways that underlie physiological processes. Typically, electroceutical devices are either implanted or wearable, depending on the condition being treated. For example, deep brain stimulators, vagus nerve stimulators, and spinal cord stimulators are commonly used implantable electroceuticals. These devices deliver precisely controlled electrical signals to alter abnormal nerve activity, helping to restore normal function or alleviate symptoms. Recent advancements in neuroscience, bioengineering, and miniaturization have driven innovation in this field, enabling more targeted and less invasive treatments. Electroceuticals are considered promising in areas where conventional drug therapies may fall short due to side effects, limited efficacy, or resistance. By harnessing the body's electrical system, electroceuticals open up new possibilities for personalized and precise medical interventions, potentially transforming the way chronic diseases are managed in the future.

Electroceuticals Market- Market Dynamics

Rising Prevalence of Neurological Disorders Driving Demand

The increasing incidence of neurological disorders is significantly contributing to the growth of the electroceuticals market. Conditions such as Parkinson's disease, epilepsy, chronic depression, Alzheimer's disease, and multiple sclerosis are becoming more prevalent due to factors like aging populations, lifestyle changes, and improved diagnostic capabilities. These disorders often have limited treatment options, and conventional pharmaceutical approaches may lead to inadequate results or undesirable side effects. As a result, there is a growing shift toward advanced therapeutic solutions that offer greater precision and fewer systemic impacts. Electroceuticals provide a novel approach by directly targeting neural circuits responsible for disease symptoms through electrical stimulation. Technologies such as deep brain stimulation (DBS), vagus nerve stimulation (VNS), and spinal cord stimulation (SCS) have shown considerable success in managing complex neurological conditions. With better outcomes in symptom control and patient quality of life, these devices are gaining traction among healthcare providers and patients alike.

ELECTROCEUTICALS Market- Key Insights

According to our research analyst, the global Electroceuticals Market is expected to develop at a CAGR of approximately 7.60% between 2024-2032.

Segmented by Product in 2023, the Cardiac Pacemakers & Implantable Cardioverter Defibrillators category dominated the market.

Based on type, the Implantable Electroceutical Devices generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Electroceuticals Market- Segmentation Analysis:

The global Electroceuticals market is divided into three categories: product, type, application and region.

The electroceuticals market is segmented by product into Cardiac Pacemakers & Implantable Cardioverter Defibrillators (ICDs), Cochlear Implants, Neuromodulators, and Retinal Implants. Among these, Cardiac Pacemakers & ICDs are expected to dominate the market. This dominance is primarily driven by the high global prevalence of cardiovascular diseases, including arrhythmias and heart failure, which require timely intervention through electrical stimulation of the heart. These devices are widely adopted due to their proven efficacy, technological advancements, and increasing use in aging populations who are more susceptible to heart conditions. Additionally, the availability of reimbursement policies in developed countries and ongoing innovation in minimally invasive cardiac devices further boost their adoption. While cochlear implants and neuromodulators are growing segments, the long-standing clinical use, robust infrastructure, and life-saving potential of cardiac devices secure their leading position in the market. As cardiovascular diseases remain a leading cause of mortality worldwide, demand for these devices is expected to remain strong.

By type electroceuticals market is segmented into Implantable Electroceutical Devices and Noninvasive Electroceutical Devices. Among these, Implantable Electroceutical Devices hold the dominant share of the market. This dominance is attributed to their widespread application in treating critical, chronic conditions such as cardiac arrhythmias, epilepsy, and Parkinson's disease. Devices like cardiac pacemakers, implantable cardioverter defibrillators (ICDs), deep brain stimulators, and vagus nerve stimulators offer targeted therapy with high efficacy and long-term benefits, making them the preferred choice for severe medical conditions. Implantable devices also benefit from continuous advancements in miniaturization, battery technology, and device programming, which enhance their safety and performance. Furthermore, their long-standing clinical acceptance and robust reimbursement frameworks in developed markets support broader adoption. Although noninvasive devices are gaining traction for mild conditions and home-based therapies, implantable electroceuticals continue to lead the market due to their therapeutic precision and life-saving applications.

Electroceuticals Market- Geographical Insights

Geographically, the Electroceuticals Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds the largest share of the global electroceuticals market, with the United States as the primary contributor. The region benefits from a robust healthcare infrastructure, high healthcare spending, and rapid adoption of advanced medical technologies. A rising prevalence of chronic disorders-such as Parkinson's disease, epilepsy, cardiovascular conditions, and hearing loss-drives consistent demand for implantable devices like cardiac pacemakers, ICDs, cochlear implants, and deep brain stimulators. Additionally, the presence of key market players such as Medtronic, Abbott, and Boston Scientific ensures strong research, development, and commercialization pipelines. Regulatory agencies such as the U.S. FDA provide a well-defined framework for medical device approvals, promoting innovation and market entry. Moreover, favorable reimbursement policies and growing physician and patient awareness further support market expansion. The U.S. also leads in clinical trials and academic research focused on neuromodulation and bioelectronic medicine. Canada, while smaller in market size, also contributes through public healthcare initiatives and increased access to advanced treatments. As the region continues to invest in personalized medicine, digital health integration, and miniaturized bioelectronic devices, North America is expected to maintain its leadership in the electroceuticals landscape over the coming years.

Europe stands as the second-largest market for electroceuticals, driven by an aging population and a rising incidence of neurological and cardiovascular disorders. Countries such as Germany, the United Kingdom, and France are major revenue generators due to their advanced healthcare infrastructure, comprehensive insurance coverage, and proactive regulatory support. The region has shown a strong inclination toward adopting innovative therapeutic technologies, including deep brain stimulation, vagus nerve stimulation, and cochlear implants. Europe is home to prominent academic institutions and research centers contributing to bioelectronic medicine development. Funding from both public health bodies and the European Union fosters the growth of clinical research and device innovation. Furthermore, high patient awareness and clinician expertise in neuromodulation therapies bolster adoption rates. Reimbursement frameworks in many European countries support access to high-cost medical technologies, thereby increasing patient uptake of electroceutical treatments.

Electroceuticals Market- Competitive Landscape:

The electroceuticals market is highly competitive, with dominance from established medical device manufacturers such as Medtronic, Boston Scientific Corporation, and Abbott, who leverage extensive R&D capabilities, regulatory expertise, and global distribution networks. These companies focus on expanding their portfolios through innovative solutions in cardiac devices, neuromodulation, and hearing implants. LivaNova Plc, Cochlear Ltd., and Sonova specialize in niche segments like vagus nerve stimulation and cochlear implants, enhancing patient outcomes in neurological and auditory disorders. Meanwhile, emerging players such as Axonics Inc., Neuronetics, ElectroCore Inc., and NeuroPace Inc. are driving innovation through minimally invasive and wearable neuromodulation technologies targeting conditions like depression, epilepsy, and overactive bladder. MicroPort Scientific Corporation and Nervo Corp. are expanding their footprint in Asia and North America, respectively. This competitive landscape, characterized by strategic acquisitions, partnerships, and continuous product development, fosters a dynamic environment that promotes technology advancement and broader adoption of electroceutical therapies worldwide.

Recent Developments:

In April 2024, Axonics Inc. announced FDA approval for its next-generation rechargeable sacral neuromodulation system, offering longer battery life and improved patient comfort.

In January 2024, Boston Scientific Corporation acquired Relievant Medsystems, a company specializing in intraosseous basivertebral nerve ablation therapy, to expand its chronic pain management portfolio.

In November 2023, Abbott received CE Mark approval for its Eterna(TM) spinal cord stimulation system, featuring its smallest implantable rechargeable neurostimulator designed for chronic pain relief.

In September 2023, Neuronetics launched the NeuroStar Advanced Therapy System in new markets across Europe, expanding access to transcranial magnetic stimulation (TMS) for major depressive disorder.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ELECTROCEUTICALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Livanova Plc
  • Cochlear Ltd.
  • Microport Scientific Corporation
  • Sonova
  • Nervo Corp.
  • Axonics Inc.
  • Neuronetics
  • Electrocore Inc.
  • Neuropace Inc.
  • Others

GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • Cochlear Implants
  • Neuromodulators
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Vagus Nerve Stimulators
  • Sacral Nerve Stimulators
  • Gastric Electrical Stimulators
  • Transcranial Magnetic Stimulators
  • Respiratory Electrical Stimulators
  • Trigeminal Nerve Stimulators
  • Responsive Neurostimulators
  • Retinal Implants

GLOBAL ELECTROCEUTICALS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Implantable Electroceutical Devices
  • Noninvasive Electroceutical Devices

GLOBAL ELECTROCEUTICALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiac Pacemakers & Implantable Cardioverter Defibrillators
  • Arrhythmia
  • Heart Failure
  • Other Cardiac Pacemaker & Icd Applications
  • Spinal Cord Stimulators
  • Chronic Pain
  • Failed Back Surgery Syndrome
  • Ischemia
  • Deep Brain Stimulators
  • Parkinson's Disease
  • Tremors
  • Depression
  • Other DBS Applications
  • Sacral Nerve Stimulators
  • Urine Incontinence
  • Fecal Incontinence
  • Vagus Nerve Stimulators
  • Epilepsy
  • Other VNS Applications
  • Gastric Electrical Stimulators
  • Gastroparesis
  • Obesity
  • Transcutaneous Electrical Nerve Stimulators
  • Treatment-Resistant Depression
  • Other TENS Application
  • Transcranial Magnetic Stimulators
  • Depression
  • Migraine
  • Respiratory Electrical Stimulators
  • Spinal Cord Injury
  • Trigeminal Nerve Stimulators
  • Attention-Deficit/Hyperactivity Disorder
  • Migraine

GLOBAL ELECTROCEUTICALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Electroceuticals Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Electroceuticals Market Snippet by Product
    • 2.1.2. Electroceuticals Market Snippet by Type
    • 2.1.3. Electroceuticals Market Snippet by Application
    • 2.1.4. Electroceuticals Market Snippet by Country
    • 2.1.5. Electroceuticals Market Snippet by Region
  • 2.2. Competitive Insights

3. Electroceuticals Key Market Trends

  • 3.1. Electroceuticals Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Electroceuticals Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Electroceuticals Market Opportunities
  • 3.4. Electroceuticals Market Future Trends

4. Electroceuticals Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Electroceuticals Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Electroceuticals Market Landscape

  • 6.1. Electroceuticals Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Electroceuticals Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
    • 7.1.3. Cochlear Implants
    • 7.1.4. Neuromodulators
      • 7.1.4.1. Spinal Cord Stimulators
      • 7.1.4.2. Deep Brain Stimulators
      • 7.1.4.3. Vagus Nerve Stimulators
      • 7.1.4.4. Sacral Nerve Stimulators
      • 7.1.4.5. Gastric Electrical Stimulators
      • 7.1.4.6. Transcranial Magnetic Stimulators
      • 7.1.4.7. Respiratory Electrical Stimulators
      • 7.1.4.8. Trigeminal Nerve Stimulators
      • 7.1.4.9. Responsive Neurostimulators
    • 7.1.5. Retinal Implants

8. Electroceuticals Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 8.1.2. Implantable Electroceutical Devices
    • 8.1.3. Non-invasive Electroceutical Devices

9. Electroceuticals Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
      • 9.1.2.1. Arrhythmia
      • 9.1.2.2. Heart Failure
      • 9.1.2.3. Other Cardiac Pacemaker & Icd Applications
    • 9.1.3. Spinal Cord Stimulators
      • 9.1.3.1. Chronic Pain
      • 9.1.3.2. Failed Back Surgery Syndrome
      • 9.1.3.3. Ischemia
    • 9.1.4. Deep Brain Stimulators
      • 9.1.4.1. Parkinson's Disease
      • 9.1.4.2. Tremors
      • 9.1.4.3. Depression
      • 9.1.4.4. Other Dbs Applications
    • 9.1.5. Sacral Nerve Stimulators
      • 9.1.5.1. Urine Incontinence
      • 9.1.5.2. Fecal Incontinence
    • 9.1.6. Vagus Nerve Stimulators,
      • 9.1.6.1. Epilepsy
      • 9.1.6.2. Other Vns Applications
    • 9.1.7. Gastric Electrical Stimulators
      • 9.1.7.1. Gastroparesis
      • 9.1.7.2. Obesity
    • 9.1.8. Transcutaneous Electrical Nerve Stimulators
      • 9.1.8.1. Treatment-Resistant Depression
      • 9.1.8.2. Other Tens Application
    • 9.1.9. Transcranial Magnetic Stimulators
      • 9.1.9.1. Depression
      • 9.1.9.2. Migraine
    • 9.1.10. Respiratory Electrical Stimulators
      • 9.1.10.1. Spinal Cord Injury
    • 9.1.11. Trigeminal Nerve Stimulators
      • 9.1.11.1. Attention-Deficit/Hyperactivity Disorder
      • 9.1.11.2. Migraine

10. Electroceuticals Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Electroceuticals Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Electroceuticals Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Electroceuticals Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Electroceuticals Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Electroceuticals Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Electroceuticals Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
    • 11.2.2. Boston Scientific Corporation
    • 11.2.3. Abbott
    • 11.2.4. Livanova Plc
    • 11.2.5. Cochlear Ltd.
    • 11.2.6. Microport Scientific Corporation
    • 11.2.7. Sonova
    • 11.2.8. Nervo Corp.
    • 11.2.9. Axonics Inc.
    • 11.2.10. Neuronetics
    • 11.2.11. Electrocore Inc.
    • 11.2.12. Neuropace Inc.
    • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us